<DOC>
	<DOC>NCT01914419</DOC>
	<brief_summary>The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via intravenous (IV) infusion or IV bolus reduces the rate of postpartum hemorrhage compared to intramuscular (IM) injection.</brief_summary>
	<brief_title>Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage</brief_title>
	<detailed_description>The study will compare the effect of IV infusion or IV bolus to IM oxytocin administration with respect to mean blood loss and the proportion of women who experience blood loss greater than or equal to 500 ml, women who experience blood loss greater than or equal to 350 ml, side effects, adverse events and change in hemoglobin pre- to post-delivery.</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>All women who present in active labor for a live birth at the study hospital will be considered for participation in the study Planned or transferred for delivery via Cesarean section Administration of a predelivery uterotonic to induce or augment labor Unable to provide informed consent due to mental impairment, distress during labor or other reason</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Prevention</keyword>
	<keyword>Third stage of labor</keyword>
	<keyword>Hemoglobin</keyword>
	<keyword>Intravenous</keyword>
	<keyword>Intramuscular</keyword>
	<keyword>Bolus</keyword>
</DOC>